Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-23

FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for doxylamine succinate and pyridoxine hydrochloride from Actavis Pharma, Inc., for use in nausea and vomiting during p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (doxylamine succinate and pyridoxine hydrochloride)

Snippet

SUPPL AP for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)